Business

GSK launches as soon as day-to-day, single inhaler-triple treatment for COPD patients

GlaxoSmithKline Pharmaceuticals on Tuesday said it has launched Trelegy Ellipta for Chronic Obstructive Pulmonary Disease (COPD) patients. Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is the first once daily single-inhaler triple therapy (SITT) in India for COPD patients. The product launch comes after the Drugs Controller General of India (DCGI) approved the use of Trelegy Ellipta as maintenance…

Published

1 year ago

April 26, 2022

Shrishti

GSK launches as soon as day-to-day, single inhaler-triple treatment for COPD patients

GlaxoSmithKline Prescription pills on Tuesday stated it has launched Trelegy Ellipta for Power Obstructive Pulmonary Illness (COPD) patients. Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is the first as soon as day-to-day single-inhaler triple treatment (SITT) in India for COPD patients. The product initiate comes after the Tablets Controller Long-established of India (DCGI) permitted the use of Trelegy Ellipta as maintenance treatment to prevent and support signs associated to Power Obstructive Pulmonary Illness (COPD) in patients feeble 18 and above…
Read Extra

Business

Main person cos to proceed capex

Several leading consumer facing companies including Hindustan Unilever, Britannia, Voltas, Havells, Blue Star and Titan Company are going to continue their high capital expenditure (capex) and expansion this fiscal as that in FY23, senior executives told ET and analysts in recent earning calls.Much of the capex is ear-marked for new factories…

Published

3 weeks ago

May 16, 2023

Shrishti

A lot of main person facing companies together with Hindustan Unilever, Britannia, Voltas, Havells, Blue Smartly-known person and Titan Company are going to proceed their excessive capital expenditure (capex) and growth this fiscal as that in FY23, senior executives informed ET and analysts in contemporary incomes calls.Much of the capex is ear-marked for ticket spanking contemporary factories…
Read Extra